Skip to main content

Table 3 Models fitting results

From: An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets

Model term

TP1a

T4b

R2

0.9921

0.9881

Adjusted R2

0.9862

0.9723

Predicted R2

0.9758

0.9613

  1. aTheoretical plates of peak number (1) corresponding to Aspirin
  2. bTailing factor of peak number (4) corresponding to Clopidogrel
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us